5th Pharmacovigilance Congregation 2013

Top Quote "Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management" 20th November 2013, Kohinoor Continental Hotel, Mumbai, India. End Quote
  • (1888PressRelease) November 20, 2013 - KEY THEMES DISCUSSED IN THIS CONFERENCE:-
    Exploiting the latest technologies, methodologies & automations on work practices of Pharmacovigilance
    Keeping abreast of the changes impacting the drug safety industry to ensure the pharmacovigilance strategies are robust and geared to compliance
    Recent successful strategies and business models to bring out new medicines
    How will PV activities change with Clinical Trial Transformation Initiative?
    Identifying essential antidote requirements and learn to implement best practices in drug safety and surveillance
    Exploiting the pharmacy automations and technologies for enhancement of medication safety
    Stay ahead of computing and electronic communications in pharmacovigilance
    Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market
    Establishing the importance of pharmacovigilance for the safety of the patient
    Determining the steps and strategies for enhancing quality in healthcare
    Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
    Analyzing the information on current industry projects and trends
    Identifying the latest regulatory framework for pharmacovigilance
    Global marketing strategies in order to engage with regulatory centres of excellence on pharmacovigilance
    Accelerating new medicine introduction in developing world & overcoming challenges
    Explaining how to use the data sources and observational research for effective safety analysis
    Good supply chain management practices for medicine distribution
    Be part of a major networking opportunity

    KEY SPEAKERS:-
    Deepa Arora, Global Head, Drug Safety & Risk Management, Lupin
    Arun Bhatt, President, Clininvent Research
    Moin Don, Executive Director, PVCON Pharmacovigilance Auditing & Consulting Services & Head Pharmacovigilance, Reliance Clinical Research

    Services
    Bhaswat Chakraborty, Senior Vice President, Research & Development, Cadila Pharmaceuticals
    Parminder Kaur, Owner & Regulatory Affairs & PhV Consultant (QPPV), RegPak BioPharma Consulting (Netherlands, UK)
    Babita Kirodian, Head - Pharmacovigilance, Bristol-Myers Squibb
    Rajani Rokade, Head - Pharmacovigilance, Sanofi Aventis
    Veena Rajan, Head - Patient Safety, AstraZeneca
    Sofi Joseph, Head - Regulatory Operations, Pfizer
    Manish Mistry, Medical Director, Novartis
    Abhay Chimankar, Global Safety Officer, Cipla
    Girish Parhate, Senior Manager - Regulatory Affairs, Bayer
    Indu Nambiar, Clinical Safety Officer, Boehringer Ingelheim
    Prashant Bodhe, Director, CliniSearch
    Deepti Sanghavi, Senior Medical Writer - Medical Writing, SIRO Clinpharm
    Milind Antani, Head - Pharma LifeSciences group, Nishith Desai Associates
    Anish Desai, Director Medical Affairs and Clinical Operations, Johnson & Johnson
    Plus Many More....

    WHO SHOULD ATTEND:-
    Vice Presidents, Directors, CRO's, Heads and Managers of:
    Pharmacovigilance Strategy
    Drug Safety/Risk Management
    Information and Clinical Data Management
    Clinical Research
    Research & Development
    Product Safety/Assurance Assessment
    Patient Safety & Outcomes Research & Data Analysis
    Epidemiology project management
    Regulatory Affairs and Compliance
    Sales & Marketing
    Biotech manufacturers

    WHY SHOULD YOU ATTEND:-

    Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

    CONFERENCE BOOKING DETAILS:-

    Early Bird Discounted Price - Conference Delegate Pass (INR 4,000 + Tax (12.36%) per delegate) - Book and Pay before 07th October 2013 to avail the early bird discounted price. You can simply email or call and book your conference delegate seats on TEL: + 91 44 65150714. Email - nisha @ virtueinsight . com
    Standard Price After Early Bird Discounted Time - 1 or 2 Delegates (INR 5,000 + Tax (12.36%) per delegate) - You can simply email or call and book your conference delegate seats on TEL: + 91 44 65150714. Email - nisha @ virtueinsight . com
    Group Discounts - 3 and above Delegates - (INR 4,000 + Tax (12.36%) per delegate)
    Spot Registration on the day of the Conference - 1 Day Conference - (INR 6,000 + Tax (12.36%) per delegate)
    Conference Sponsor & Exhibition Stall - Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to - TEL: + 91 44 65150714. Email - nisha @ virtueinsight . com

    For more info on the event and for event brochure kindly visit -
    http://www.virtueinsight.com/pharma/5th-Pharmacovigilance-Congregation-2013/

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information